Literature DB >> 33360384

Host transcriptome response to Borrelia burgdorferi sensu lato.

Derick Thompson1, John A Watt2, Catherine A Brissette3.   

Abstract

The host immune response to infection is a well-coordinated system of innate and adaptive immune cells working in concert to prevent the colonization and dissemination of a pathogen. While this typically leads to a beneficial outcome and the suppression of disease pathogenesis, the Lyme borreliosis bacterium, Borrelia burgdorferi sensu lato, can elicit an immune profile that leads to a deleterious state. As B. burgdorferi s.l. produces no known toxins, it is suggested that the immune and inflammatory response of the host are responsible for the manifestation of symptoms, including flu-like symptoms, musculoskeletal pain, and cognitive disorders. The past several years has seen a substantial increase in the use of microarray and sequencing technologies to investigate the transcriptome response induced by B. burgdorferi s.l., thus enabling researchers to identify key factors and pathways underlying the pathophysiology of Lyme borreliosis. In this review we present the major host transcriptional outcomes induced by the bacterium across several studies and discuss the overarching theme of the host inflammatory and immune response, and how it influences the pathology of Lyme borreliosis.
Copyright © 2020 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Borrelia burgdorferi; Borreliosis; Host transcriptome; Lyme

Mesh:

Year:  2020        PMID: 33360384      PMCID: PMC8127729          DOI: 10.1016/j.ttbdis.2020.101638

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  164 in total

1.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2.

Authors:  M Hirschfeld; C J Kirschning; R Schwandner; H Wesche; J H Weis; R M Wooten; J J Weis
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  TREM1 Blockade: Killing Two Birds with One Stone.

Authors:  Marco Colonna
Journal:  Trends Immunol       Date:  2019-08-20       Impact factor: 16.687

3.  Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

Authors:  J D Farrar; J D Smith; T L Murphy; S Leung; G R Stark; K M Murphy
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

Review 4.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 5.  γδ T Cells and dendritic cells in refractory Lyme arthritis.

Authors:  Ali Divan; Ralph C Budd; Richard P Tobin; M Karen Newell-Rogers
Journal:  J Leukoc Biol       Date:  2015-01-20       Impact factor: 4.962

6.  Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue.

Authors:  Christine Rouault; Vanessa Pellegrinelli; Raphaela Schilch; Aurélie Cotillard; Christine Poitou; Joan Tordjman; Henrike Sell; Karine Clément; Danièle Lacasa
Journal:  Endocrinology       Date:  2013-01-31       Impact factor: 4.736

7.  The clinical evolution of Lyme arthritis.

Authors:  A C Steere; R T Schoen; E Taylor
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

Review 8.  Fibroblasts-a diverse population at the center of it all.

Authors:  J Michael Sorrell; Arnold I Caplan
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 9.  Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.

Authors:  Thiago A Patente; Mariana P Pinho; Aline A Oliveira; Gabriela C M Evangelista; Patrícia C Bergami-Santos; José A M Barbuto
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.